相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
Adele K. Fielding et al.
BLOOD (2014)
How will B-cell-receptor-targeted therapies change future CLL therapy?
Jeffrey A. Jones et al.
BLOOD (2014)
Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV
Ruediger Hehlmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis
Oliver Teuffel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Xavier C. Badoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Acute lymphoblastic leukaemia
Hiroto Inaba et al.
LANCET (2013)
Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial
A. K. Burnett et al.
LEUKEMIA (2013)
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129
Dan Douer et al.
LEUKEMIA RESEARCH (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome-Positive Leukemias
J. E. Cortes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Meta-Analysis of Randomised Clinical Trials Comparing Idarubicin plus Cytarabine with Daunorubicin plus Cytarabine as the Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukaemia
Jing Wang et al.
PLOS ONE (2013)
Minimal Residual Disease-Based Risk Stratification in Chinese Childhood Acute Lymphoblastic Leukemia by Flow Cytometry and Plasma DNA Quantitative Polymerase Chain Reaction
Suk Hang Cheng et al.
PLOS ONE (2013)
A 50-Year Journey to Cure Childhood Acute Lymphoblastic Leukemia
Ching-Hon Pui et al.
SEMINARS IN HEMATOLOGY (2013)
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy
Ezhilarasi Chendamarai et al.
BLOOD (2012)
Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia
Kenneth A. Foon et al.
BLOOD (2012)
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial
Jonathan I. Sive et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
The History of Leukemia Therapy-A Personal Journey
Emil J. Freireich
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2012)
New agents for acute myeloid leukemia: is it time for targeted therapies?
Felicetto Ferrara
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Predicting survival in chronic lymphocytic leukemia
Ali Bazargan et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Hagop M. Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The discovery and early understanding of leukemia
Kim R. Kampen
LEUKEMIA RESEARCH (2012)
High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia
Wing Leung et al.
BLOOD (2011)
A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia
Je-Hwan Lee et al.
BLOOD (2011)
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance
Giuseppe Avvisati et al.
BLOOD (2011)
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Robin Foa et al.
BLOOD (2011)
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
Bayard L. Powell et al.
BLOOD (2010)
History of leukemia-lymphoma cell lines
Hans G. Drexler et al.
HUMAN CELL (2010)
Single Cycle of Arsenic Trioxide-Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia
Steven D. Gore et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
Pierre Fenaux et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome-Negative Precursor B-Lineage Acute Lymphoblastic Leukemia
Deborah A. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
A. Moericke et al.
LEUKEMIA (2010)
Chronic Myeloid Leukemia: A Historical Perspective
John M. Goldman
SEMINARS IN HEMATOLOGY (2010)
Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden
Sigurdur Y. Kristinsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials
John Koreth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Kirk R. Schultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Perspectives on the development of imatinib and the future of cancer research
Brian J. Druker
NATURE MEDICINE (2009)
Anthracycline Dose Intensification in Acute Myeloid Leukemia
Hugo F. Fernandez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Treatment of Children With Acute Promyelocytic Leukemia: Results of the First North American Intergroup Trial INT0129
John Gregory et al.
PEDIATRIC BLOOD & CANCER (2009)
Notch signaling in leukemia
Jon C. Aster et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival:: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
Anja Moericke et al.
BLOOD (2008)
Current management and challenges of malignant disease in the CNS in paediatric leukaemia
Ching-Hon Pui et al.
LANCET ONCOLOGY (2008)
Trepanning or trephines: a history of bone marrow biopsy
Liakat A. Parapia
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Junia V. Melo et al.
NATURE REVIEWS CANCER (2007)
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment
Alan K. Burnett et al.
CANCER (2007)
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993
JM Rowe et al.
BLOOD (2005)
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia
W Wierda et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
All-trans retinoic acid in acute promyelocytic leukemia:: long-term outcome and prognostic factor analysis from the North American Intergroup protocol
MS Tallman et al.
BLOOD (2002)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The treatment of acute leukemia: past, present, and future
E Beutler
LEUKEMIA (2001)
Leukaemia - a brief historical review from ancient times to 1950
GJ Piller
BRITISH JOURNAL OF HAEMATOLOGY (2001)